EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Optimizing CAR-T therapy delivery in the Italian healthcare system: economic and organizational insights in follicular lymphoma

Andrea Vitagliano, Marzia Bonfanti, Emanuele Angelucci iD, Alice Di Rocco, Maria Paola Martelli iD, Elena Del Sarto, Marianna Morani iD, Chiara Lucchetti, Simona Palladino

Global and Regional Health Technology Assessment · 09.06.2026 · 13 (1) · 133-145

DOI: 10.33393/grhta.2026.3722 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Global and Regional Health Technology Assessment, online erschienen am 09.06.2026. Verfasst von Andrea Vitagliano und 8 weiteren Autor:innen. Beteiligte Einrichtung: Pharmalex Italy S.p.A., Milan - Italy. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Follicular Lymphoma (FL) is the second most common lymphoid malignancy, with 20% of patientsprogressing within 24 months of first-line therapy. Chimeric antigen receptor T-cell (CAR-T) therapies have improved outcomes in relapsed or refractory FL, yet their use requires significant resources and complex care pathways. Although outpatient CAR-T programs have shown promising safety and feasibility, limited evidence exists on their organizational, economic, and ethical implications in the Italian healthcare setting. This study compares the current CAR-T pathway for FL patients with a virtual optimized scenario incorporating outpatient management in selected phases.

Methods

A multidimensional framework was applied to assess differences between standard in-hospital care(Standard Pathway) across three Italian public hospitals (Genoa, Rome, Perugia) and a partially outpatient model(Efficient Pathway). Literature review and expert consultations validated existing practices and informed optimization criteria. Structured surveys provided quantitative and qualitative inputs. Economic modelling estimated three-year full costs using patient-level data, while organizational and ethical aspects were evaluated through Likert scales.

Results

Efficient Pathway shifted bridging therapy, post-infusion monitoring, and follow-up to outpatient settings,reducing total costs from € 611,070 (As-Is) to € 497,421 (To-Be). Organizational benefits included increasedbed capacity (average score: 4.9/6) and consumable utilization (average score: 4.3/6), while ethical gains wereobserved in treatment accessibility (average score: 4.3/6).

Conclusions

Introducing outpatient management into CAR-T phases may provide economic, organizational, andethical advantages when supported by clear eligibility criteria and structured monitoring. As CAR-T indicationsexpand, pathway redesign will be essential to ensure equitable access and sustain healthcare system resources.

Schlagwörter

Stichwörter der Autor:innen

CAR-TEconomic impactFollicular LymphomaOrganizational impactOutpatient

Autor:innen und Institutionen

  • Pharmalex Italy S.p.A., Milan - Italy.
  • IRCCS Ospedale Policlinico San Martino, Genova - Italy.
  • Azienda Ospedaliero Universitaria Policlinico Umberto I, Rome - Italy.
  • Dipartimento di Medicina Traslazionale e di Precisione Sapienza, Università di Roma, Rome - Italy.
  • Azienda Ospedaliera di Perugia, Perugia - Italy.
  • Centro Ricerche Emato-Oncologiche, Università di Perugia, Perugia - Italy.

ORCID-Profile: Emanuele Angelucci, Maria Paola Martelli, Marianna Morani

Zitieren

APA

Vitagliano, A., Bonfanti, M., Angelucci, E., Di Rocco, A., Martelli, M. P., Sarto, E. D., Morani, M., Lucchetti, C., & Palladino, S. (2026). Optimizing CAR-T therapy delivery in the Italian healthcare system: economic and organizational insights in follicular lymphoma. Global and Regional Health Technology Assessment, 13(1), 133-145. https://doi.org/10.33393/grhta.2026.3722

Vancouver

Vitagliano A, Bonfanti M, Angelucci E, Di Rocco A, Martelli MP, Sarto ED, et al. Optimizing CAR-T therapy delivery in the Italian healthcare system: economic and organizational insights in follicular lymphoma. Global and Regional Health Technology Assessment. 2026;13(1):133-145. doi:10.33393/grhta.2026.3722

BibTeX
@article{Vitagliano2026,
  author = {Vitagliano, Andrea and Bonfanti, Marzia and Angelucci, Emanuele and Di Rocco, Alice and Martelli, Maria Paola and Sarto, Elena Del and Morani, Marianna and Lucchetti, Chiara and Palladino, Simona},
  title = {Optimizing CAR-T therapy delivery in the Italian healthcare system: economic and organizational insights in follicular lymphoma},
  journal = {Global and Regional Health Technology Assessment},
  year = {2026},
  volume = {13},
  number = {1},
  pages = {133--145},
  doi = {10.33393/grhta.2026.3722}
}
Kostenlos starten →